Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
Crossref DOI link: https://doi.org/10.1186/s12944-016-0302-8
Published Online: 2016-08-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shah, Parth
Glueck, Charles J.
Jetty, Vybhav
Goldenberg, Naila
Rothschild, Matan
Riaz, Rashid
Duhon, Gregory
Wang, Ping
Funding for this research was provided by:
lipoprotein research fund